Team Finds Few Abnormalities in AML Genomes

Using SNP microarrays and gene re-sequencing, a group of researchers from St. Jude Children's Hospital and the National Cancer Institute characterized more than 100 AML tumors, revealing a smaller-than-expected burden of copy number alterations and point mutations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories